Microba Life Sciences joins Microbiome Therapeutics Group
WASHINGTON, Feb. 22, 2021 — The Microbiome Therapeutics Innovation Group (MTIG) announced today the addition of Microba Life Sciences to its coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products.
Press Releases: